Journal article

Warfarin is not the anticoagulant of choice for malignancy-associated venous thromboembolism

Timothy D Clay, Philip Craven, Eli Gabbay

INTERNAL MEDICINE JOURNAL | WILEY | Published : 2019

DOI: 10.1111/imj.14343

Download PDF

University of Melbourne Researchers

Keywords

Venous Thromboembolism
Humans
Medicine, General & Internal
Warfarin
Science & Technology
General & Internal Medicine
Anticoagulants
Pulmonary Embolism
Neoplasms
Life Sciences & Biomedicine